German Pharmacies. Figures Data Facts Legal disclosure:
|
|
- Phillip Stevenson
- 6 years ago
- Views:
Transcription
1 German Pharmacies Figures Data Facts 2009 Legal disclosure: Published by the ABDA Federal Union of German Associations of Pharmacists Jägerstr. 49/ Berlin Germany Print: blueprint berlin gmbh Sources: ABDA-Statistik Bundesministerium für Gesundheit Center for Drug Information and Pharmacy Practice Europäische Kommission Gesundheit Österreich GmbH, ÖBIG 2006 IMS HEALTH GmbH & Co. OHG infas Institut für angewandte Sozialwissenschaft GmbH Institut für Demoskopie Allensbach Pro Generika e.v. Reader's Digest Statistisches Bundesamt The Nielsen Company GmbH Verein Deutsches Arzneiprüfungsinstitut e.v. YouGovPsychonomics AG
2 Contents Community pharmacies Numbers of pharmacies...4 Pharmacies in the German states... 5 Trends in the number of jobs in community pharmacies Pharmacists and pharmacy students... 8 Pharmacy trainee positions... 9 Pharmacy services Pharmacy image Pharmacy density in Europe Community pharmacies Pharmacies in the health care system SHI expenditure on pharmaceuticals (excl. co-payments) Distribution of the value added Allocation of total SHI expenditure Distribution of miscellaneous costs Vaccine sales Statutory pharmacy and manufacturer rebates Rebated pharmaceuticals Co-payments for pharmaceuticals Co-pay exemptions Pharmaceuticals with and without reference price Prescribed pharmaceuticals (SHI) Pharmaceutical expenditure per SHI-member Pharmaceutical expenditure per person Distributions of pharmacies according to turnover Structure of pharmacy sales Structure of complementary product range Drug-related problems (DRP) concerning self-medication VAT on pharmaceuticals in the EU
3 Numbers of pharmacies Pharmacies in the German states Number of pharmacies (incl. subsidiaries) German state Public Independent pharmacies in 2009 pharmacies* Subsidiaries Baden-Württemberg 2,755 2, ,569 21,465 21,305 21,392 21,476 21,551 21,570 21,602 21,548 Bavaria 3,439 2, Berlin Brandenburg Subsidiaries Bremen Hamburg ,228 1,796 2,356 2,851 3,224 Hesse 1,621 1, Mecklenburg-West Pomerania Lower Saxony 2,107 1, Pharmacies opened North Rhine 2,507 2, Westphalia-Lippe 2,230 1, Rhineland-Palatinate 1, Saarland Pharmacies closed Saxony Saxony-Anhalt Schleswig-Holstein Thuringia Total 21,548 18,324 3,224 Figures as at year-end Figures as at year-end; * Pharmacies with operating licence in accordance with 2 of the Apothekengesetz (pharmacy regulations) 4 5
4 Trends in the number of jobs in community pharmacies Year-end Pharmacists 45,869 46,513 46,140 Of which female (%) ,014 46,276 46,953 47,766 48,030 48, Pre-registration trainee pharmacists 1,748 1,520 1,387 1,431 1,534 1,518 1,506 1,327 1,287 Pharmaceutical engineers 10,294 10,218 9,600 9,602 9,266 8,292 8,413 8,196 8,056 Pharmaceutical technical assistants (PTA) 40,805 41,495 42,385 43,946 46,431 48,656 49,874 51,907 53,734 Pharmaceutical commercial employees (PCE) / other 38,614 40,091 37,636 35,812 36,454 38,355 36,026 36,020 35,769 Total jobs 137, , , , , , , , ,
5 Pharmacists and pharmacy students Pharmacy trainee positions Pharmacists Pharmacists in: Percentage of women Community pharmacies 48,030 48, Of which managers 18,751 18, ,287 Hospital pharmacies 1,874 1, Industry, administration, organisation, science 7,575 7, Total emloyed pharmacists 57,479 57, ,155 2,645 Pharmacy students 2004/ , / ,069 10,087 Total number of trainee positions 2006/ , / ,721 PCEs in training Pre-registration trainee pharmacists PTA trainees 2008/ ,
6 Pharmacy services Pharmacy image Approximately 4 million people visit public pharmacies every day. In 2009, pharmacies 87 % of Germans have a high degree of trust in pharmacists 1 - reported a total of 7,400 suspected cases of medication risks to the Drug Commission of the German Medical Association. Main complaints referred to errors in packaging (30 %), unwanted medication effects and reports of misuse (29 %) as well as galenic deficiency (20 %). --processed some 16 million prescriptions covered by the statutory health insurance (SHI), 65 % of which were conventional, 20 % methadone, 11 % cytostatic and 4 % parenteral formulation. Training courses 82 % 65 % of Germans feel that pharmacies provide good-quality service, and consider them to be some of the best service providers in Germany 2 of Germans go to the pharmacy first when they have minor health issues 3 In 2009, approximately 119,000 people took part in nearly 2,300 training courses offered by the Council of Pharmacists more than ever before. Grade 2.4 is the mark Germans give to owner-run pharmacies and is equivalent to good 4 Night and emergency service - Approx. 2,000 pharmacies per night Grade 1.8 is the mark Germans give to owner-run pharmacies concerning healthcare of their children 5 - More than 20,000 patients per night - More than 7 million packs provided outside the regular opening hours - Especially important for children (and their parents): above-average percentage of SHI pharmaceuticals dispensed during night and emergency service is prescribed by paediatricians. Sources (representative surveys) 1 Reader's Digest Allensbach YouGovPsychonomics infas infas
7 Pharmacy density in Europe People per pharmacy* Denmark 16,800 Sweden 10,700 Netherlands 9,400 Slovenia 7,400 Austria 6,900 Finland 6,500 Pharmacies in the health care system Czech Republic 5,500 Luxembourg 5,200 Hungary 5,000 United Kingdom 4,900 Slovakia 4,600 Estonia 4,300 Germany 3,800 Portugal 3,800 Poland 3,500 Italy 3,300 Ireland 3,000 France 2,700 Latvia 2,600 Lithuania 2,300 Spain 2,100 Belgium 2,000 Malta 1,900 Cyprus 1,700 Greece 1,200 * Germany: ABDA-Statistik 2009; all other countries: last available year according to ÖBIG 12 13
8 SHI expenditure on pharma ceuticals (excl. co-payments) Distribution of the value added Every 100 spent by SHI on pharmaceuticals is allocated as follows: (=14.9 %) 4.49 (=16.0 %) (=65.2 %) Industry (=3.9 %) In bn (=100 %) Total amount spent by SHI on pharmaceuticals in 2009 Exchequer (VAT) Pharmaceutical industry and purchased materials and services (such as raw materials) Pharmaceutical wholesalers VAT (exchequer) Pharmacies Wholesalers Pharmacies 14 15
9 Allocation of total SHI expenditure Total SHI expenditure (in bn) Of which (%) Doctors Dentists Dentures Remedies and therapeutic aids Hospitals Administrative expenditure Misc. costs Pharmaceuticals** Of which is allocated to pharmacies based on the Drug Price Ordinance (Arzneimittelpreisverordnung) * * Provisional ** From pharmacies 16 17
10 Distribution of miscellaneous costs Vaccine sales* in % In m Sick pay 4.2 Transportation expenses Pregnancy, maternity 1.9 Home care ,257 Pharmaceuticals from others ,349 Social services 1.5 Ambulant & inpatient treatment, rehab ,176 Dialysis in doctors' practices 1.0 Early diagnosis measures 0.9 Others 2.0 Of which tick-borne meningoencephalitis Of which flu Of which pneumococcus Of which human papillomavirus (HPV) Total 18.2 In 2007, vaccinations were included in the SHI catalogue of required services. * Vaccine against H1N1 ("swine-flu") is not included, as settlement is undertaken by the Federal States
11 Statutory pharmacy and manufacturer rebates Rebated pharmaceuticals 9,300 Number of rebate contracts 1,235 1,319 1, Involved health insurance companies Involved pharmaceutical manufacturers 26,900 Number of rebated pharmaceuticals (Central Pharmaceutical Number) 60 % Share of rebated pharmaceuticals subject to no or reduced co-payments Mio. Rebated packs of generic pharmaceuticals In m Pharmacy rebate Manufacturer rebates (excl. rebate contracts) 20.9 Mio. Number of data sets that need to be processed by Pharmacy IT Figures as at year-end
12 Co-payments for pharmaceuticals Co-pay exemptions Co-payments in m Number of patients who are exempt from the prescription charge (hardship cases in accordance with 62 SGB V): 6,643,362 6,837,531 2,314 2,149 1,979 1,626 1,674 1, Number of patients who exceed the annual prescription charge limit of 2 % of their gross annual income: Charge per unit in 673, , Number of patients who exceed the annual prescription charge limit of 1 % of their gross annual income (chronically ill patients): ,969,805 6,403,
13 Pharmaceuticals with and without reference price Prescribed pharmaceuticals (SHI) Average unit price in Prescriptions per member Pharmaceuticals per prescription Prescribed pharmaceuticals per member x x x Pharmaceuticals with reference price Pharmaceuticals without reference price x x x Number of units provided in m x x x x Pharmaceuticals with reference price Pharmaceuticals without reference price 24 25
14 Pharmaceutical expenditure per SHI member * Per member (excl. pensioners) in Per pensioner in Per member (incl. pensioners) in Approx. 30 % of the members are pensioners. *Provisional 26 27
15 Pharmaceutical expenditure per person Distribution of pharmacies according to turnover Pharmacy share according to turnover (%) Pharmaceutical expenditure per person Total: 515 Over-the-counter pharmaceuticals Prescription pharmaceuticals <0.50 <0.75 <1.00 <1.25 <1.50 <1.75 <2.00 <2.25 <2.50 <2.75 <3.00 >3.00 Incl. VAT Turnover in m (excl. VAT) 28 29
16 Structure of pharmacy sales Measured in sales value: Measured per units: Pharmacy sales in 2009 (excl.vat) 39.2 bn = 100 % Prescriptions in ,426 m units = 100 % 1) 2.0 bn = 5.1 % Pharmaceuticals 35.5 bn = 90.6 % 2) 1.7 bn = 4.3 % Prescription pharmaceuticals 766 m units = 53.7 % Pharmacy-only pharmaceuticals (non-prescription) 614 m units = 43.1 % 1) 46 m = 3.2 % Prescription pharmaceuticals 30.8 bn = 78.6 % Pharmacy-only pharmaceuticals (non-prescription) 4.4 bn = 11.2 % 3) 0.3 bn = 0.8 % Prescribed 121 m units = 8.5 % Not prescribed 493 m units = 34.6 % Prescribed 1.1 bn = 2.8 % Not prescribed 3.3 bn = 8.4 % Volume of pharmaceuticals covered by SHI, private insurance and other 887 m units = 62.2 % Self-medication 539 m units = 37.8 % Value of pharmaceuticals covered by SHI, private insurance or other Self-medication 31.9 bn = 81.4 % 3.6 bn = 9.2 % 1) Supplementary assortment 2) Patient care products 3) Unrestricted OTC pharmaceuticals* 1) Unrestricted OTC pharmaceuticals* * Pharmaceuticals which may be sold outside pharmacies (e.g. by chemists) 30 31
17 Structure of complementary product range Drug-related problems (DRP) concerning self-medication Almost every 5th patient request for self-medication pharmaceuticals is associated with one or more drug-related problems (DRP) % of DRP occur in conjunction with the four most common indications, i.e. pain, respiratory-, gastrointestinal- and skin disorders % of DRP are inappropriate self-medication, inappropriate product request, wrong dosage, and duration of drug use (including abuse) was too long. 0.3 If a patient has a medication record at the pharmacy, significantly more cases of wrong dosage and drug-drug interactions can be identified % of DRP can be resolved in pharmacies. 3.7 Total Sales in bn (excl. VAT) Medical products and therapeutic aids Hygienic and cosmetic products Vitamins and minerals Other * includes supplementary assortment and patient care products 32 33
18 VAT on pharmaceuticals in the EU* Tax rate for pharmaceuticals General VAT rate Tax rate for pharmaceuticals General VAT rate Denmark Bulgaria Germany Greece Latvia Italy Hungary Lithuania Portugal Spain Luxembourg France Refundable pharmaceuticals Austria Non-refundable pharmaceuticals 5.5 Slovakia Sweden Prescription pharmaceuticals Estonia Over-the-counter pharmaceuticals 25.0 Romania Ireland Oral medication Czech Republic Non-oral medication 21.5 Slovenia UK National Health Service pharmaceuticals Finland Over-the-counter pharmaceuticals 15.0 Poland Belgium Malta Cyprus Netherlands * Tax rates as at
ABOUT THE ABDA GERMAN PHARMACIES FIGURES, DATA, FACTS 2018
ABOUT THE ABDA»» The ABDA Federal Union of German Associations of Pharmacists is the foremost organisation for pharmacists in Germany. The ABDA represents the interests of the pharmaceutical healthcare
More informationABOUT THE ABDA GERMAN PHARMACIES FIGURES, DATA, FACTS 2016
ABOUT THE ABDA The ABDA Federal Union of German Associations of Pharmacists is the foremost organisation for pharmacists in Germany. The ABDA represents the interests of the pharmaceutical healthcare professions
More informationABOUT THE ABDA GERMAN PHARMACIES FIGURES, DATA, FACTS 2017
ABOUT THE ABDA The ABDA Federal Union of German Associations of Pharmacists is the foremost organisation for pharmacists in Germany. The ABDA represents the interests of the pharmaceutical healthcare professions
More informationSmokefree Policies in Europe: Are we there yet?
Smokefree Policies in Europe: Are we there yet? 14 April 2015, 9:00 10:30am Rue de l Industrie 24, 1040 Brussels Permanent Partners: Temporary Partners: The research for the SFP Smokefree Map was partially
More informationCross Border Genetic Testing for Rare Diseases
Cross Border Genetic Testing for Rare Diseases EUCERD Joint Action WP8 Helena Kääriäinen National Institute for Health an Welfare, Helsinki, Finland Starting point Possibilities and demand for genetic
More informationWCPT COUNTRY PROFILE December 2017 HUNGARY
WCPT COUNTRY PROFILE December 2017 HUNGARY HUNGARY NUMBERS WCPT Members Practising physical therapists 727 Total number of physical therapist members in your member organisation 4,000 Total number of practising
More informationWCPT COUNTRY PROFILE December 2017 SWEDEN
WCPT COUNTRY PROFILE December 2017 SWEDEN SWEDEN NUMBERS WCPT Members Practising physical therapists 11,043 Total number of physical therapist members in your member organisation 17,906 Total number of
More informationWCPT COUNTRY PROFILE December 2017 SERBIA
WCPT COUNTRY PROFILE December 2017 SERBIA SERBIA NUMBERS WCPT Members Practising physical therapists 622 Total number of physical therapist members in your member organisation 3,323 Total number of practising
More informationThe health economic landscape of cancer in Europe
1 Approval number The health economic landscape of cancer in Europe Bengt Jönsson, Professor Emeritus of Health Economics Stockholm School of Economics 2 Disclaimer This presentation was developed by Professor
More informationOverview of drug-induced deaths in Europe - What does the data tell us?
Overview of drug-induced deaths in Europe - What does the data tell us? João Matias, Isabelle Giraudon, Julián Vicente EMCDDA expert group on the key-indicator Drug-related deaths and mortality among drug
More informationEuropean Community Pharmacy: a reference in Public Health
European Community Pharmacy: a reference in Public Health Ilaria Passarani PGEU Secretary General 4 October 2018, Burgos, Spain Pharmaceutical Group of European Union Members: Professional Bodies & Pharmacists
More informationResearch paper: Legal treatment of the use of cannabis for medical purposes in the member states of the European Union
Parliament of Montenegro Parliamentary Institute Research Centre Research paper: Legal treatment of the use of cannabis for medical purposes in the member states of the European Union Podgorica, December
More informationREPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT, THE COUNCIL, THE EUROPEAN ECONOMIC AND SOCIAL COMMITTEE AND THE COMMITTEE OF THE REGIONS
EUROPEAN COMMISSION Brussels, 17.6.011 COM(011) 35 final REPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT, THE COUNCIL, THE EUROPEAN ECONOMIC AND SOCIAL COMMITTEE AND THE COMMITTEE OF THE REGIONS
More informationPharmacy Ownership and Establishment
Pielikums Nr.2 Pharmacy Ownership and Establishment Ref: 09.07.06E 012FS Pharmacy Ownership and Establishment Ownership information on who is entitled to own a Pharmacy. Reference should be made if ownership
More informationNutrient profiles for foods bearing claims
Nutrient profiles for foods bearing claims Fields marked with * are mandatory. Background Regulation (EC) 1924/2006 (Nutrition and Health Claims NHC Regulation) establishes EU rules on nutrition and health
More informationTEDDY. Teddy Network of Excellence. Annagrazia ALTAVILLA. Ph.D. Sciences Ethics LL.M. Health Law. diterranée
Teddy Network of Excellence Annagrazia ALTAVILLA TEDDY Task-force in Europe for Drug Development for the Young Ph.D. Sciences Ethics LL.M. Health Law Associated Senior Lecturer Université de la MéditerranM
More informationRheumatoid Arthritis Disease Burden and Access to Treatment
Berlin, April 2012 Rheumatoid Arthritis Disease Burden and Access to Treatment Gisela Kobelt, PhD Visiting Professor, Lund University (Sweden) President, European Health Economics (France) Disclaimers
More informationUnderage drinking in Europe
Underage drinking in Europe There are two major studies on underage drinking which are published every 4 years: HBSC (Health Behaviour in School-aged Children) and ESPAD (The European School survey Project
More informationFebruary Public Opinion Poll. Personalized Cancer Medicine
February 2018 Public Opinion Poll Personalized Cancer Medicine Public Opinion Poll Germany Personalized Cancer Medicine Summary Germans are most afraid of cancer (67%, p. 5). Correspondingly important
More informationEuropean Collaboration on Dementia. Luxembourg, 13 December 2006
European Collaboration on Dementia Luxembourg, 13 December 2006 2005 Call for projects Special attention has also to be given to information and definition of indicators on neurodegenerative, neurodevelopment,
More informationPARALLELISM AND THE LEGITIMACY GAP 1. Appendix A. Country Information
PARALLELISM AND THE LEGITIMACY GAP 1 Appendix A Country Information PARALLELISM AND THE LEGITIMACY GAP 2 Table A.1 Sample size by country 2006 2008 2010 Austria 2405 2255 0 Belgium 1798 1760 1704 Bulgaria
More informationCost of Disorders of the Brain in Europe Gustavsson et al. Cost of disorders of the brain in Europe Eur. Neuropsych. (2011) 21,
Cost of Disorders of the Brain in Europe 2010 Gustavsson et al. Cost of disorders of the brain in Europe 2010. Eur. Neuropsych. (2011) 21, 718-779 Steering Committee Prof Jes Olesen 1 Prof Bengt Jönsson
More informationLEBANON. WCPT COUNTRY PROFILE December 2018
LEBANON WCPT COUNTRY PROFILE December 2018 LEBANON NUMBERS 1600 1400 1200 1000 800 600 400 200 0 Physical therapists in the country Members in MO 1,480 1,480 Total PTs in country 800000 700000 600000 500000
More informationBiology Report. Is there a relationship between Countries' Human Development Index (HDI) level and the incidence of tuberculosis?
Biology Report Is there a relationship between Countries' Human Development Index (HDI) level and the incidence of tuberculosis? Introduction Tuberculosis is a serious disease caused by the bacterium Mycobacterium
More informationManuel Cardoso RARHA Executive Coordinator Public Health MD Senior Advisor Deputy General-Director of SICAD - Portugal
Manuel Cardoso RARHA Executive Coordinator Public Health MD Senior Advisor Deputy General-Director of SICAD - Portugal Public Health Public health is the science and art of preventing disease, prolonging
More informationHomeopathy and Anthroposophic Medicine THEIR PLACE IN EUROPEAN HEALTH CARE
Homeopathy and Anthroposophic Medicine THEIR PLACE IN EUROPEAN HEALTH CARE A thriving European tradition Homeopathy and anthroposophic medicine are part of a long-standing European therapeutic tradition
More informationState of provision of Hearing Aids in Europe
Creating a barrier-free Europe for all hard of hearing citizens State of provision of Hearing Aids in Europe 2018 Report 1 Executive Summary Dear Reader, We are pleased to share the report examining affordability
More informationEuropean Status report on Alcohol and Health
European Status report on Alcohol and Health Dr Lars Moller Regional Advisor a.i. WHO Regional Office for Europe Main killers in the WHO European Region Source: Preventing chronic diseases. A vital investment.
More informationThe Current Status of Cardiac Electrophysiology in ESC Member Countries J. Brugada, P. Vardas, C. Wolpert
Albania. Algeria. Armenia. Austria. Belarus. Belgium. Bosnia & Herzegovina. Bulgaria. Croatia. Cyprus. Czech Republic Denmark. Egypt. Estonia. Finland. Former Yugoslav Republic of Macedonia. France. Georgia.
More informationEstimating Illegal Activities in Denmark
Estimating Illegal Activities in Denmark Table of Contents Executive summary... 3 Introduction... 4 1. Smuggling of alcohol and tobacco, etc.... 5 1.1 Introduction... 5 1.1.1 Consequences in the national
More informationDENMARK. WCPT COUNTRY PROFILE December 2018
DENMARK WCPT COUNTRY PROFILE December 2018 DENMARK NUMBERS 14000 12000 10000 8000 6000 4000 2000 0 Physical therapists in the country Members in MO 11,720 12,975 Total PTs in country 800000 700000 600000
More informationMonthly measles and rubella monitoring report
SURVEILLANCE REPORT Monthly measles and rubella monitoring report December 2018 Period covered: 1 November 2017 to 31 October 2018 Introduction This monitoring report is based on measles and rubella data
More informationInequalities in health: challenges and opportunities in Europe Dr Zsuzsanna Jakab WHO Regional Director for Europe
Inequalities in health: challenges and opportunities in Europe Dr Zsuzsanna Jakab WHO Regional Director for Europe 21st Congress of the European Association of Dental Public Health 1 October 2016 Budapest
More informationIs there a relationship between Countries' Human Development Index (HDI) level and the incidence of tuberculosis?
Is there a relationship between Countries' Human Development Index (HDI) level and the incidence of tuberculosis? Introduction Tuberculosis is a serious disease caused by the bacterium Mycobacterium tuberculosis.
More informationGERMANY. WCPT COUNTRY PROFILE December 2018
GERMANY WCPT COUNTRY PROFILE December 2018 GERMANY NUMBERS 160000 140000 120000 100000 80000 60000 40000 20000 0 Physical therapists in the country Members in MO 21,502 136,000 Total PTs in country 800000
More informationGlobal Trade in Lightweight Coated Writing Paper TradeData International Pty Ltd (www.tradedata.net) Page 1 5/18/2015
Page 1 5/18/2015 An Analysis of Global Trade in Lightweight paper, coated with inorganic substances, used for writing etc., of which more than 10% by weight of total fibre content consists of fibres obtained
More informationWhere do EU Contries set the limit for low risk drinking.
Where do EU Contries set the limit for low risk drinking. Results from the EU RARHA survey E. Scafato,L. Galluzzo, S. Ghirini, C. Gandin Istituto Superiore di Sanità, Italy WP5: Outline of the work (tasks)
More informationYersiniosis SURVEILLANCE REPORT. Annual Epidemiological Report for Key facts. Methods. Epidemiology
SURVEILLANCE REPORT Annual Epidemiological Report for 2015 Yersiniosis Key facts In 2015, 26 countries reported 7 279 confirmed yersiniosis cases in the EU/EEA. The overall notification rate was 2.0 cases
More informationWhere we stand in EFORT
Where we stand in EFORT Engaging with the new EU regulatory landscape for medical devices. Challenges & opportunities Brussel, Belgium April 6, 2018 Per Kjaersgaard-Andersen Associate Professor Section
More informationFinnish international trade 2017 Figures and diagrams. Finnish Customs Statistics
Finnish international trade 217 Figures and diagrams Finnish Customs Statistics IMPORTS, EXPORTS AND TRADE BALANCE 199-217 Billion e 7 6 5 4 3 2 1-1 9 91 92 93 94 95 96 97 98 99 1 2 3 4 5 6 7 8 9 1 11
More informationAlcohol Prevention Day
Alcohol Prevention Day Rome, 16 May 2018 Hana Horka Policy Officer, Unit C4 Health Determinants and International Relations European Commission DG Health and Food Safety (SANTE) Alcohol consumption in
More informationFinnish international trade 2017 Figures and diagrams. Finnish Customs Statistics
Finnish international trade 217 Figures and diagrams Finnish Customs Statistics IMPORTS, EXPORTS AND TRADE BALANCE 199-217 Billion e 7 6 5 4 3 2 1-1 9 91 92 93 94 95 96 97 98 99 1 2 3 4 5 6 7 8 9 1 11
More informationQ1 What age are you?
Q1 What age are you? Answered: 504 Skipped: 0 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 4.56% 23 3.77% 19 4.56% 23 6.15% 31 3.97% 20 6.55% 33 5.95% 30 6.75% 34 6.35% 32 4.37% 22 6.75% 34 5.56%
More informationThe cancer burden in the European Union and the European Region: the current situation and a way forward
The cancer burden in the European Union and the European Region: the current situation and a way forward Presented by Zsuzsanna Jakab WHO Regional Director for Europe Informal Meeting of Health Ministers
More informationTrichinellosis SURVEILLANCE REPORT. Annual Epidemiological Report for Key facts. Methods
Annual Epidemiological Report for 2015 Trichinellosis Key facts In 2015, a total of 156 confirmed cases of trichinellosis was reported from 29 EU/EEA countries. The overall notification rate was 0.03 cases
More informationMedia Release. Inaugural study reveals that more than one in four women in European and Central Asian prisons locked up for drug offences
Media Release Embargoed 00.01 CET Monday 12 th March 2012 Inaugural study reveals that more than one in four women in European and Central Asian prisons locked up for drug offences Up to 70 percent of
More informationMen & Health Work. Difference can make a difference Steve Boorman & Ian Banks RSPH Academy 2013
Men & Health Promotion @ Work Difference can make a difference Steve Boorman & Ian Banks RSPH Academy 2013 Difference can make a Difference Mens health: State of mens health Use of services Role of the
More informationPharmaceutical, Medical and Health-related Government and Regulatory bodies around the world.
1 International International Conference on Harmonization (ICH) World Health Organization (WHO) 2 Argentina National Administration of Drugs, Food and medical Technology. Australia s Department of health
More informationScreening for Cervical Cancer in Europe
Asturias, 23 October, 2011 Asturias, 23 October Screening for Cervical Cancer in Europe M. Arbyn Unit Cancer Epidemiology, IPH, Brussels, Belgium Rue Juliette Wytsmanstraat 14 1050 Brussels Belgium T +32
More informationCOMMISSION OF THE EUROPEAN COMMUNITIES
COMMISSION OF THE EUROPEAN COMMUNITIES Brussels, 22.12.2008 COM(2008) 882 final REPORT FROM THE COMMISSION TO THE COUNCIL, THE EUROPEAN PARLIAMENT, THE EUROPEAN ECONOMIC AND SOCIAL COMMITTEE AND THE COMMITTEE
More informationEuropean status report on alcohol and health Leadership, awareness and commitment
European status report on alcohol and health 2014 Leadership, awareness and commitment Leadership, awareness and commitment Background Strong leadership from national and local governments is essential
More informationProject Meeting Prague
Project Meeting Prague IO1 Assessment 9.11.217 CHRISTINA PADBERG ON BEHALF OF FRANKFURT UAS Current Status Assessment matrix was fully evaluated Experts have been interviewed, Interviews were fully evaluated
More informationAlcohol-related harm in Europe and the WHO policy response
Alcohol-related harm in Europe and the WHO policy response Lars Moller Programme Manager World Health Organization Regional Office for Europe Date of presentation NCD global monitoring framework: alcohol-related
More informationEuropean Association of Dental Public Health Prevention of Oral Cancer
European Association of Dental Public Health Prevention of Oral Cancer Special Interest Working Group Thursday 14th November 2013 PD Dr. Katrin Hertrampf, MPH Dr. Colwyn Jones, Associate Editor Malta 2013
More informationThe EHRA White Book 2009 The Current Status of Cardiac Electrophysiology in ESC Member Countries J. Brugada, P. Vardas, C. Wolpert
Albania. Algeria. Armenia. Austria. Belarus. Belgium. Bosnia & Herzegovina. Bulgaria. Croatia. Cyprus. Czech Republic Denmark. Egypt. Estonia. Finland. Former Yugoslav Republic of Macedonia. France. Georgia.
More informationOpen Access & research metrics Establishing reliable baselines for science policy
Open Access & research metrics Establishing reliable baselines for science policy Thed van Leeuwen, Rodrigo Costas, Alfredo Yegros-Yegros, and Ingeborg Meijer CWTS, Leiden University STI Conference 2017,
More informationMember State Marketing autorisation Holder Invented Name Strength Pharmaceutical form Route of administration
ANNEX I LIST OF THE NAMES, PHARMACEUTICAL FORM, STRENGTH OF THE MEDICINAL PRODUCTS, ROUTE OF ADMINISTRATION, MARKETING AUTHORISATION HOLDERS IN THE MEMBER STATES 1 Member State Marketing autorisation Holder
More informationMEDICINES SHORTAGES PGEU GPUE. John Chave - Secretary general. Pharmaceutical Group of European Union Groupement Pharmaceutique de l Union Européenne
MEDICINES SHORTAGES John Chave - Secretary general Members: Professional Bodies & Pharmacists Associations 2013: 32 Countries Austria Belgium Bulgaria Bosnia Herzegovina Cyprus Czech Rep Denmark Estonia
More informationPublic administration reforms and public sector performance in Central and Eastern Europe EU member states: in EU perspective
Public administration reforms and public sector performance in Central and Eastern Europe EU member states: in EU perspective Prof. Ing. Juraj Nemec, CSc. Masaryk University, Czech Republic, Size of government
More informationThomas Karlsson & Esa Österberg National Research and Development Centre for Welfare and Health Alcohol and Drug Research Group P.O.
European Comparative Alcohol Study Europe and Alcohol Policy Thomas Karlsson & Esa Österberg National Research and Development Centre for Welfare and Health Alcohol and Drug Research Group P.O.BO 220 FIN-00531
More informationUK bowel cancer care outcomes: A comparison with Europe
UK bowel cancer care outcomes: A comparison with Europe What is bowel cancer? Bowel cancer, which is also known as colorectal or colon cancer, is a cancer that affects either the colon or the rectum. The
More informationREPORT ON LAWS AND RECOMMENDATIONS ON DENTAL MERCURY MANAGEMENT IN THE EU
0 REPORT ON LAWS AND RECOMMENDATIONS ON DENTAL MERCURY MANAGEMENT IN THE EU 31/01/2018 0 1 Contents 1. Introduction... 2 2. Phasing out the use of dental amalgam... 3 3. Use of encapsulated dental amalgam...
More informationRisk perception and food safety: where do European consumers stand today?
Risk perception and food safety: where do European consumers stand today? Lucia de Luca Press Officer, EFSA Outline Objective Methodology Risk perceptions Views on public authorities action Sources of
More informationPerspectives from regions: successes and challenges in promoting seasonal influenza vaccine usage in the EU
Perspectives from regions: successes and challenges in promoting seasonal influenza vaccine usage in the EU N. Safrany European Commission Pr. A. Nicoll ECDC 2 nd WHO GAP mtg 12-14 July 2011 Background
More informationClinical Evidence in the Daily Work of an Anthroposophic Hospital Dr. med. Harald Matthes, Medical Director, Havelhöhe Hospital in Berlin
Programme Venue: Time: Chair: Presentations: Members Salon, European Parliament 8:00 9:30 am Marian Harkin MEP Research Evidence in Homeopathy: Overview of published clinical investigations Robert Mathie
More informationAlcohol in Europe and Brief Intervention. Dr Lars Møller Programme Manager World Health Organization Regional Office for Europe
Alcohol in Europe and Brief Intervention Dr Lars Møller Programme Manager World Health Organization Regional Office for Europe Global risk factors ranked by attributable burden of disease 2010 (GBD, Lancet,
More informationPrevention of Oral Cancer Special Interest Working Group
Prevention of Oral Cancer Special Interest Working Group Dr Colwyn Jones, Consultant in Dental Public Health, NHS Health Scotland, 1 South Gyle Crescent, Edinburgh EH12 9EB, Scotland. colwyn.jones@nhs.net
More information(Adopted by the Committee of Ministers on 19 January 2011 at the 1103rd meeting of the Ministers Deputies)
Resolution CM/ResAP(2011)1 on quality and safety assurance requirements for medicinal products prepared in pharmacies for the special needs of patients (Adopted by the Committee of Ministers on 19 January
More informationThe Risk of Alcohol in Europe. Bridging the Gap June 2004
The Risk of Alcohol in Europe Bridging the Gap 16-19 June 2004 1. What is the relationship between alcohol and the risk of heart disease? 2. What is the relationship between alcohol and the risk of other
More informationHighly pathogenic avian influenza "The Epidemic" Regionalisation in the European Union
Highly pathogenic avian influenza "The 2016-2017 Epidemic" Regionalisation in the European Union Andrea Gavinelli, Head of Unit G3 Official controls and eradication of diseases in animals European Commission
More informationOutcome of proficiency test on EIA serology
Outcome of proficiency test on EIA serology Anses Dozulé Laboratory for equine diseases VIPARE unit Delphine Gaudaire EIA PT GENERAL INFORMATION AIM OF THE PT Detect EIA antibodies: using Agar Gel Immuno-Diffusion
More informationOverall survival: 1 st line therapy
1 3 Overall survival: 1 st line therapy 2-year OS phase III studies mm Prices per month of oncology medicin Bloomberg Business weekly 26 Feb 2015 Presented By Veena Shankaran at 2016 ASCO Annual Meeting
More informationWho is a migrant? 12/10/2018. HIV and migrants. Heterogeneous groups of persons with different migration drivers
HIV and migrants Julia del Amo has received research grants awarded to her institution from Companies BMS, Gilead, ViiV and epidemiology teaching fees from ViiV, Gilead and MSD Dr Julia del Amo National
More informationALCOHOL CONSUMPTION IN EUROPE; TRADITIONS, GENERATIONS, CULTURE AND POLICY
ALCOHOL CONSUMPTION IN EUROPE; TRADITIONS, GENERATIONS, CULTURE AND POLICY JACEK MOSKALEWICZ INSTITUTE OF PSCHIATRY AND NEUROLOGY WARSAW, POLAND THIRD EUROPEAN CONFERENCE ON ALCOHOL AND LAW ENFORCEMENT,
More informationCups & Filters. 2.5ml sterile cup 100 pcs bag 100 and more Handle. Cotton filter 1000 pcs carton 5000 and more
Tools for harm reduction Tél: +33 (0) 1 53 61 18 41 - Fax: +33 (0) 1 53 61 04 49 Cups & Filters Tool Composition Packaging Quantity Number of pieces Total Stericup* 2.5ml sterile cup 100 pcs bag 100 and
More informationMARKET NEWS for pigmeat
MARKET NEWS for pigmeat Market analysis 12 February 2018 Week 7 MARKET SITUATION Europe: Trading in fresh legs is at increasing prices. With regard to other cuts, trading is at slightly increasing prices.
More informationDrinking guidelines used in the context of early identification and brief interventions in Europe: overview of RARHA survey results
Drinking guidelines used in the context of early identification and brief interventions in Europe: overview of RARHA survey results E. Scafato, C. Gandin, L. Galluzzo, S. Ghirini, S. Martire Istituto Superiore
More informationreal-time AQ data 2007 and plans for 2008
real-time AQ data 2007 and plans for 2008 Tim Haigh - project manager Information Resources http://www.eea.europa.eu/maps/ozone/map/ Where is all the data coming from? EEA NRT Database 4000 2000 700 EEA
More informationIOSH No Time to Lose campaign: working together to tackle asbestos-related cancer #NTTLasbestos. Jonathan Hughes IOSH Vice President
IOSH No Time to Lose campaign: working together to tackle asbestos-related cancer #NTTLasbestos Jonathan Hughes IOSH Vice President About the Institution of Occupational Safety and Health (IOSH) www.iosh.co.uk
More informationSOITC Press Ad FAQs. Q: When will these Terms and Conditions changes come into effect?
SOITC Press Ad FAQs Q: Why are AIB changing their services and charging options? A: With the Payment Services Directive II (PSD2) coming into force in 13 th January 2018, AIB are taking this opportunity
More informationEngagement in language assessment / Regions of Europe
Summary table: Engagement in language / Regions of This table lists the statistically significant differences in the engagement in activities by the respondents from different s of : If the word or appears
More informationCurrent levels and recent trends in health inequalities in the EU: Updates from the EU Report
Current levels and recent trends in health inequalities in the EU: Updates from the EU Report Anne Scott London Health Observatory Expert Working Group on Social Determinants and Health Inequalities Luxembourg,
More informationExtrapolation and potential impact of IPHS deployment in Europe
SIMPHS2 Validation Workshop Brussels, 31 Jan 2012 1 SIMPHS2 Validation Workshop Extrapolation and potential impact of IPHS deployment in Europe JRC IPTS IS Unit Ioannis Maghiros, Fabienne Abadie, Maria
More informationOverview of European Consumption Databases
FEDERAL INSTITUTE FOR RISK ASSESSMENT Overview of European Consumption Databases Katrin Büsch Workshop Food Consumption Data and Dietary Exposure in the European Union, 15-16 May 2008, Berlin Introduction
More informationEHFG 2016 Sustainable and equitable cancer care: tomorrow s reality or science-fiction?
1 Approval number EHFG 2016 Sustainable and equitable cancer care: tomorrow s reality or science-fiction? 28 th September 2016 The Oncologist s perspective What can and should be changed in order to optimise
More informationExpert Peer Review for Carfentanil
Expert Committee on Drug Dependence Thirty-ninth Meeting Geneva, 6-10 November 2017 Expert Peer Review for Carfentanil 1. Comments based on the review report a. Evidence on dependence and abuse potential
More informationState of Health In EU: Community Pharmacy Contribution
State of Health In EU: Community Pharmacy Contribution #PGEUSoH www.pgeu.eu SYLVAIN GIRAUD DG SANTE #PGEUSoH GAÉTAN LAFORTUNE OECD #PGEUSoH CHALLENGES TO EU HEALTH SYSTEMS EMBARGOED UNTIL PUBLICATION OF
More informationSign Language Act in Europe and Hungary by dr. Ádám Kósa
Sign Language Act in Europe and Hungary by dr. Ádám Kósa Member of the European Parliament co-chair of the Disability Intergroup president of the Hungarian Association of the Deaf and Hard-of- Hearing
More information'SECTION B EU PARTY. The following abbreviations are used:
'SECTION B EU PARTY The following abbreviations are used: AT Austria BE Belgium BG Bulgaria CY Cyprus CZ Czech Republic DE Germany DK Denmark ES Spain EE Estonia EU European Union, including all its Member
More informationA new scale to measure tobacco control activity in a country: data tables and questionnaire
A new scale to measure tobacco control activity in a country: data tables and questionnaire 1 Appendix 1: Smoke free public places - score on 1 July 2005 in 30 European countries Country Bars and restaurants
More informationReal Life, Real PD Survey
Real Life, Real PD Survey Final Pan-European Survey Results Survey Objectives The survey was carried out to provide insights into the realities of living with PD and to highlight some of the symptoms of
More informationAnimal species. Member State EU/EEA. Route of administration. Strength. Applicant Name INN Pharmaceutical form. Austria 1
Annex I List of the names, pharmaceutical form, strength of the veterinary medicinal product, animal species, route of administration, applicant in the Member States 1 Member State EU/EEA Applicant Name
More informationEstimating Smoking Related Cause of Death: a Cohort Approach Based on Lung Cancer Mortality in six European Countries
1 Estimating Smoking Related Cause of Death: a Cohort Approach Based on Lung Cancer Mortality in six European Countries Introduction Mariachiara Di Cesare and Mike Murphy Department of Social Policy, London
More information